The changes of blood glucose control and lipid profiles after short-term smoking cessation in healthy males

Psychiatry Investigation

Volumn 8, Issue 2, 2011, Pages 149-154

  Lee, Seong Su ^a   Seo, Jeong Seok ^b   Kim, Sung Rae ^a   Jeong, Jo Eun ^c   Nam, Beom Woo ^b   Lee, Ju Yul ^d   Lee, Hee Jin ^a   Lee, Chul ^c   Lee, Chang Uk ^c   Paik, In Ho ^e   Chae, Jeong Ho ^c   Chai, Sook Hee ^f   Yoo, Soon Jib ^a   Won, Wang Youn ^c   Kim, Dai Jin ^c  

^a The Catholic University of Korea   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Namseoul University   (South Korea)

^e Keyo Hospital   (South Korea)

^f Eulji University   (South Korea)

Author keywords

cell function; Insulin resistance; Insulin sensitivity; Lipoprotein; Smoking cessation

Indexed keywords

ADRENALIN; ALBUMIN; CHOLESTEROL; CORTICOTROPIN; COTININE; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; PROTEIN; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADRENALIN BLOOD LEVEL; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; BODY WEIGHT; CELL ACTIVITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CORTICOTROPIN BLOOD LEVEL; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIOTHYRONINE BLOOD LEVEL; LIPID COMPOSITION; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SELF REPORT; SMOKING CESSATION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; URINALYSIS; URINE LEVEL; WEIGHT CONTROL;

EID: 79960939124     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2011.8.2.149     Document Type: Article

References (45)

1. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-788.
2. Celemajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Ro-binson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-2155.
3. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J 1981;101:319-328.
4. Kannel WB. Cigarettes, coronary occlusions, and myocardial infarction. JAMA 1981;246:871-872.
5. Lakier JB. Smoking and cardiovascular disease. Am J Med 1992;93:8S-12S.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
7. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213-217.
8. Sato I, Nishida M, Okita K, Nishijima H, Kojima S, Matsumura N, et al. Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction. Jpn Circ J 1992;56:217-222.
9. Kong C, Nimmo L, Elatrozy T, Anyaoku V, Hughes C, Robinson S, et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 2001;156:373-378.
10. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
11. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bo-nora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82: 3619-3624.
12. Elkeles RS, Khan SR, Chowdhury V, Swallow MB. Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) 1983;65:669-672.
13. Richmond W, Seviour PW, Teal TK, Elkeles RS. Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) 1987;295:246-247.
14. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921.
15. Krauss RM. The tangled web of coronary risk factors. Am J Med 1991; 90:36S-41S.
16. Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003;37:283-290.
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-1127.
18. Sandberg H, Roman L, Zavodnick J, Kupers N. The effect of smoking on serum somatotropin, immunoreactive insulin and blood glucose levels of young adult males. J Pharmacol Exp Ther 1973;184:787-791.
19. Janzon L, Berntorp K, Hanson M, Lindell SE, Trell E. Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 1983;25:86-88.
20. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistan--potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-332.
21. Sargeant LA, Khaw KT, Bingham S, Day NE, Luben RN, Oakes S, et al. Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol 2001;30:547-554.
22. Niedermaier ON, Smith ML, Beightol LA, Zukowska-Grojec Z, Goldstein DS, Eckberg DL. Influence of cigarette smoking on human autonomic function. Circulation 1993;88:562-571.
23. Lucini D, Bertocchi F, Malliani A, Pagani M. A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects. Cardiovasc Res 1996;31:633-639.
24. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003; 45:405-413.
25. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997;27:450-456.
26. Mikhailidis DP, Papadakis JA, Ganotakis ES. Smoking, diabetes and hyperlipidaemia. J R Soc Health 1998;118:91-93.
27. Daniel M, Cargo MD. Association between smoking, insulin resistance and beta cell function in a North-western First Nation. Diabet Med 2004; 21:188-193.
28. Henkin L, Zaccaro D, Haffner S, Karter A, Rewers M, Sholinsky P, et al. Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Ann Epidemiol 1999;9:290-296.
29. Halfon ST, Green MS, Heiss G. Smoking status and lipid levels in adults of different ethnic origins: the Jerusalem Lipid Research Clinic Program. Int J Epidemiol 1984;13:177-183.
30. Freedman DS, Srinivasan SR, Shear CL, Hunter SM, Croft JB, Webber LS, et al. Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: the Bogalusa Heart Study. Am J Epidemiol 1986;124:207-219.
31. Kuzuya M, Ando F, Iguchi A, Shimokata H. Effect of smoking habit on age-related changes in serum lipids: a cross-sectional and longitudinal analysis in a large Japanese cohort. Atherosclerosis 2006;185:183-190.
32. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore. Atherosclerosis 1998;137:253-258.
33. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993;23:630-640.
34. Zaratin AC, Quintäo EC, Sposito AC, Nunes VS, Lottenberg AM, Morton RE, et al. Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. Metabolism 2004;53:858-862.
35. Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994;14:1581-1585.
36. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997;129:79-88.
37. Gerace TA, Hollis J, Ockene JK, Svendsen K. Smoking cessation and cha-nge in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med 1991;20:602-620.
38. Sasaki A, Kondo K, Sakamoto Y, Kurata H, Itakura H, Ikeda Y. Smoking cessation increases the resistance of low-density lipoprotein to oxidation. Atherosclerosis 1997;130:109-111.
39. Moffatt RJ, Chelland SA, Pecott DL, Stamford BA. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med 2004;38:637-641.
40. Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci (Lond) 1995;89:333-342.
41. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
42. Reaven GM. Banting Iecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
43. Delfino RJ, Jamner LD, Whalen CK. Temporal analysis of the relationship of smoking behavior and urges to mood states in men versus women. Nicotine Tob Res 2001;3:235-248.
44. Fallon JH, Keator DB, Mbogori J, Taylor D, Potkin SG. Gender: a major determinant of brain response to nicotine. Int J Neuropsychopharmacol 2005;8:17-26.
45. Kim TS, Kim DJ, Lee H, Kim YK. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci Lett 2007;423:53-57.